-
Something wrong with this record ?
The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance
G. Kharaishvili, D. Simkova, K. Bouchalova, M. Gachechiladze, N. Narsia, J. Bouchal,
Language English Country England, Great Britain
Document type Journal Article, Review
Grant support
NT13573
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
BioMedCentral
from 2001-01-12
BioMedCentral Open Access
from 2001
Directory of Open Access Journals
from 2001
Free Medical Journals
from 2001
PubMed Central
from 2001
Europe PubMed Central
from 2001
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2001-01-01
Open Access Digital Library
from 2001-11-01
Open Access Digital Library
from 2001-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
Springer Nature OA/Free Journals
from 2001-12-01
- Publication type
- Journal Article MeSH
- Review MeSH
Tumors are not merely masses of neoplastic cells but complex tissues composed of cellular and noncellular elements. This review provides recent data on the main components of a dynamic system, such as carcinoma associated fibroblasts that change the extracellular matrix (ECM) topology, induce stemness and promote metastasis-initiating cells. Altered production and characteristics of collagen, hyaluronan and other ECM proteins induce increased matrix stiffness. Stiffness along with tumor growth-induced solid stress and increased interstitial fluid pressure contribute to tumor progression and therapy resistance. Second, the role of immune cells, cytokines and chemokines is outlined. We discuss other noncellular characteristics of the tumor microenvironment such as hypoxia and extracellular pH in relation to neoangiogenesis. Overall, full understanding of the events driving the interactions between tumor cells and their environment is of crucial importance in overcoming treatment resistance and improving patient outcome.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14064307
- 003
- CZ-PrNML
- 005
- 20191025132601.0
- 007
- ta
- 008
- 140704s2014 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/1475-2867-14-41 $2 doi
- 035 __
- $a (PubMed)24883045
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kharaishvili, Gvantsa $u Laboratory of Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. $7 _AN060256
- 245 14
- $a The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance / $c G. Kharaishvili, D. Simkova, K. Bouchalova, M. Gachechiladze, N. Narsia, J. Bouchal,
- 520 9_
- $a Tumors are not merely masses of neoplastic cells but complex tissues composed of cellular and noncellular elements. This review provides recent data on the main components of a dynamic system, such as carcinoma associated fibroblasts that change the extracellular matrix (ECM) topology, induce stemness and promote metastasis-initiating cells. Altered production and characteristics of collagen, hyaluronan and other ECM proteins induce increased matrix stiffness. Stiffness along with tumor growth-induced solid stress and increased interstitial fluid pressure contribute to tumor progression and therapy resistance. Second, the role of immune cells, cytokines and chemokines is outlined. We discuss other noncellular characteristics of the tumor microenvironment such as hypoxia and extracellular pH in relation to neoangiogenesis. Overall, full understanding of the events driving the interactions between tumor cells and their environment is of crucial importance in overcoming treatment resistance and improving patient outcome.
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Šimková, Dana $u Laboratory of Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. $7 xx0221874
- 700 1_
- $a Bouchalová, Kateřina $u Department of Pediatrics and Laboratory of Experimental Medicine, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. $7 xx0045104
- 700 1_
- $a Gachechiladze, Mariam $u Laboratory of Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. $7 xx0229662
- 700 1_
- $a Narsia, Nato $u School of Cancer Sciences, University of Birmingham, Birmingham, UK.
- 700 1_
- $a Bouchal, Jan, $u Laboratory of Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. $d 1973- $7 xx0034399
- 773 0_
- $w MED00008210 $t Cancer cell international $x 1475-2867 $g Roč. 14, č. - (2014), s. 41
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24883045 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140704 $b ABA008
- 991 __
- $a 20191025133037 $b ABA008
- 999 __
- $a ind $b bmc $g 1031791 $s 863039
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 14 $c - $d 41 $i 1475-2867 $m Cancer cell international $n Cancer Cell Int $x MED00008210
- GRA __
- $a NT13573 $p MZ0
- LZP __
- $a Pubmed-20140704
